Cantab_Surgical_Group_Ltd_31_Dec_2024_companies_house_set_of

Cantab Surgical Group Ltd

Chartered accountant's report to the board of directors on the preparation of the unaudited statutory financial statements of Cantab Surgical Group Ltd

Year ended

31 December 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the

financial statements

Cantab Surgical Group Ltd

for the year ended

31 December 2024

which comprise the income statement, statement of income and retained earnings, statement of financial position and related notes from the company’s accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at icaew.com/regulations.

This report is made solely to the Board of Directors of

Cantab Surgical Group Ltd

, as a body. Our work has been undertaken solely to prepare for your approval the

financial statements

Cantab Surgical Group Ltd

and state those matters that we have agreed to state to the Board of Directors of

Cantab Surgical Group Ltd

, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than

Cantab Surgical Group Ltd

and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that

Cantab Surgical Group Ltd

has kept adequate accounting records and to prepare statutory

financial statements

that give a true and fair view of the assets, liabilities, financial position and loss of

Cantab Surgical Group Ltd

. You consider that

Cantab Surgical Group Ltd

is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Cantab Surgical Group Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

A&C Chartered Accountants

Marsland Chambers

1a Marsland Road

Sale Moor

Cheshire

M33 3HP

United Kingdom

		2024	2023
Fixed assets
Tangible assets	5	12,773		1,465
Current assets
Debtors	6	2,304		1,344
Cash at bank and in hand		699		1,831
		3,003		3,175
Creditors: amounts falling due within one year	7	(13,322	)	(803	)
Net current (liabilities)/assets		(10,319	)	2,372
Total assets less current liabilities		2,454		3,837
Provisions for liabilities		(2,427	)	-
Net assets		27		3,837
Capital and reserves
Called up share capital		100		100
Profit and loss account		(73	)	3,737
Shareholders funds		27		3,837

Cantab Surgical Group Ltd

Notes to the Financial Statements

Year ended

31 December 2024

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is

Marsland Chambers

1a Marsland Road

Sale Moor

Cheshire

M33 3HP

, England.

2 Statement of compliance

These

financial statements

have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The

financial statements

have been prepared on the historical cost basis, as modified by the revaluation of certain assets.

The

financial statements

are prepared in sterling, which is the functional currency of the company.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Current tax

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Tangible assets

Tangible assets are initially measured at cost, and are subsequently measured at cost less any accumulated depreciation and accumulated impairment losses or at a revalued amount.

Any tangible assets carried at a revalued amount are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

An increase in the carrying amount of an asset as a result of a revaluation is recognised in other comprehensive income and accumulated in capital and reserves. However, the increase is recognised in profit or loss to the extent that it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves. If a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess is recognised in profit or loss.

Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful economic life of that asset as follows:

Plant and machinery

25% reducing balance

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price and are subsequently measured as follows: Debt instruments are subsequently measured at amortised cost and commitments to receive a loan and to make a loan to another entity are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment.

All other financial instruments, including derivatives, are initially recognised at fair value, which is normally the transaction price and are subsequently measured at fair value, with any changes recognised in profit or loss.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

All equity instruments regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is more likely than not that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured on an undiscounted basis at the tax rates that would apply in the periods in which timing differences are expected to reverse, based on tax rates and laws enacted at the statement of financial position date.

Provisions for liabilities

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense.

Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.

4 Average number of employees

The average number of persons employed by the company during the year was Nil (2023: Nil).

5 Tangible assets

	Plant and machinery etc.
	£
Cost
At 1 January 2024	2,198
Additions	12,232
At 31 December 2024	14,430
Depreciation
At 1 January 2024	733
Charge	924
At 31 December 2024	1,657
Carrying amount
At 31 December 2024	12,773
At 31 December 2023	1,465

6 Debtors

	2024	2023
	£	£
Trade debtors	-	999
Other debtors	2,304	345
	2,304	1,344

7 Creditors: amounts falling due within one year

	2024	2023
	£	£
Taxation and social security	-	418
Other creditors	13,322	385
	13,322	803

8 Directors' advances, credit and guarantees

The following advances and credits to the directors S Basyuni and F Basyuni subsisted during the years ended 31 December 2023 and 31 December 2024:

S Basyuni

Balance at 01/01/2023: £0 owed to the director.

£345 was loaned to the director.

Balance at 31/12/2023: £345 owed to the company.

Balance at 01/01/2024: £345 owed to the company.

£345 was repaid by the director and £13,044 was loaned to the company.

Balance at 31/12/2024: £13,044 owed to the director.

F Basyuni

Balance at 01/01/2024: £0 owed to the director.

£264 was loaned to the company.

Balance at 31/12/2024: £264 owed to the director.

The above loans are unsecured, interest free and repayable on demand.

9 Controlling party

During the year ended 31 December 2024, the directors S Basyuni and F Basyuni controlled the company by virtue of 100% of the controlling interest.

		2024		2023
	Note	£		£
Fixed assets
Tangible assets	5	12,773		1,465
Current assets
Debtors	6	2,304		1,344
Cash at bank and in hand		699		1,831
		3,003		3,175
Creditors: amounts falling due within one year	7	(13,322	)	(803	)
Net current (liabilities)/assets		(10,319	)	2,372
Total assets less current liabilities		2,454		3,837
Provisions for liabilities		(2,427	)	-
Net assets		27		3,837
Capital and reserves
Called up share capital		100		100
Profit and loss account		(73	)	3,737
Shareholders funds		27		3,837



Dr F Basyuni	Dr S Basyuni
Director	Director